title: Analysis of cis-acting sequences required for operation of the erythropoietin 3' enhancer in different cell lines.
authors.affiliation: Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom.
authors.forename: C W
authors.initials: CW
authors.lastname: Pugh
authors.forename: B L
authors.initials: BL
authors.lastname: Ebert
authors.forename: O
authors.initials: O
authors.lastname: Ebrahim
authors.forename: P H
authors.initials: PH
authors.lastname: Maxwell
authors.forename: P J
authors.initials: PJ
authors.lastname: Ratcliffe
mesh_terms: D000818:Animals; D001483:Base Sequence; D006528:Carcinoma, Hepatocellular; D015687:Cell Hypoxia; D002460:Cell Line; D004742:Enhancer Elements, Genetic; D004921:Erythropoietin / Q000096:biosynthesis* / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms; D051379:Mice; D008969:Molecular Sequence Data; D012045:Regulatory Sequences, Nucleic Acid; D012689:Sequence Homology, Nucleic Acid; D014158:Transcription, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D004921:Erythropoietin